STAT3 and neoplasm: Antibody-mediated depletion experiments in immunocompetent mice showed that the inhibitory effect of STAT3 targeting was greatly reduced when NK cells were ablated with an anti-asialo-GMP antibody, and adoptive transfer of purified CD3−/DX5+ NK cells from tumor-bearing mice inhibited H22 tumor growth and extended survival of recipient mice.